Healios KK (HLOSF)
1.50
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Healios Enterprise Value: 117.61M for Nov. 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 117.61M |
| November 13, 2024 | 117.61M |
| November 12, 2024 | 117.61M |
| November 11, 2024 | 117.61M |
| November 08, 2024 | 117.61M |
| November 07, 2024 | 117.61M |
| November 06, 2024 | 117.61M |
| November 05, 2024 | 117.61M |
| November 04, 2024 | 117.61M |
| November 01, 2024 | 117.61M |
| October 31, 2024 | 117.61M |
| October 30, 2024 | 117.61M |
| October 29, 2024 | 117.61M |
| October 28, 2024 | 117.61M |
| October 25, 2024 | 117.61M |
| October 24, 2024 | 117.61M |
| October 23, 2024 | 117.61M |
| October 22, 2024 | 117.61M |
| October 21, 2024 | 126.62M |
| October 18, 2024 | 126.62M |
| October 17, 2024 | 126.62M |
| October 16, 2024 | 126.62M |
| October 15, 2024 | 126.62M |
| October 14, 2024 | 126.62M |
| October 11, 2024 | 126.62M |
| Date | Value |
|---|---|
| October 10, 2024 | 126.62M |
| October 09, 2024 | 126.62M |
| October 08, 2024 | 138.34M |
| October 07, 2024 | 138.34M |
| October 04, 2024 | 138.34M |
| October 03, 2024 | 138.34M |
| October 02, 2024 | 138.34M |
| October 01, 2024 | 138.34M |
| September 30, 2024 | 138.34M |
| September 27, 2024 | 138.34M |
| September 26, 2024 | 138.34M |
| September 25, 2024 | 138.34M |
| September 24, 2024 | 138.34M |
| September 23, 2024 | 138.34M |
| September 20, 2024 | 138.34M |
| September 19, 2024 | 138.34M |
| September 18, 2024 | 138.34M |
| September 17, 2024 | 138.34M |
| September 16, 2024 | 138.34M |
| September 13, 2024 | 138.34M |
| September 12, 2024 | 138.34M |
| September 11, 2024 | 138.34M |
| September 10, 2024 | 138.34M |
| September 09, 2024 | 138.34M |
| September 06, 2024 | 138.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
54.28M
Minimum
Feb 06 2024
138.34M
Maximum
Aug 30 2024
90.32M
Average
90.57M
Median
Aug 08 2024
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 72.05B |
| Nxera Pharma Co Ltd | 818.86M |
| PeptiDream Inc | 2.175B |
| AnGes Inc | 86.92M |
| SanBio Co Ltd | 247.52M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.426M |
| Revenue (Quarterly) | 3.195M |
| Total Expenses (Quarterly) | 5.004M |
| EPS Diluted (Quarterly) | -0.038 |
| Gross Profit Margin (Quarterly) | 86.35% |
| Profit Margin (Quarterly) | -107.2% |
| Earnings Yield | -31.22% |
| Normalized Earnings Yield | -31.22 |